ICAM1 and diabetic kidney disease: Normally, ICAM-1 is expressed at low levels on the surface of arterial endothelial cells, but the expression at both mRNA and protein levels are significantly increased in animal models of diabetic nephropathy with T1D [7-9] and T2D [10-12].